Subcutaneous implantable cardioverter-defibrillator and drug-induced Brugada syndrome: the importance of repeat morphology analysis during ajmaline challenge.

(risk stratification of syncope in the emergency department) study. J Am Coll Cardiol 2010;55:713–721. 15. Costantino G, Solbiati M, Casazza G, Bonzi M, Vago T, Montano N, McDermott D, Quinn J, Furlan R. Usefulness of N-terminal pro-B-type natriuretic Peptide increase as a marker for cardiac arrhythmia in patients with syncope. Am J Cardiol 2014;113: 98–102. 16. Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J 2012;29:1001–1003. 17. Shen WK, Decker WW, Smars PA, Goyal DG, Walker AE, Hodge DO, Trusty JM, Brekke KM, Jahangir A, Brady PA, Munger TM, Gersh BJ, Hammill SC, Frye RL. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation 2004; 110:3636–3645. 18. Sun BC, McCreath H, Liang LJ, Bohan S, Baugh C, Ragsdale L, Henderson SO, Clark C, Bastani A, Keeler E, An R, Mangione CM. Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission. Ann Emerg Med 2014;64:167–175. 19. Simpson C, Dorian P, Gupta A, Hamilton R, Hart S, Hoffmaster B, Klein G, Krahn A, Kryworuk P, Mitchell LB, Poirier P, Ross H, Sami M, Sheldon R, Stone J, Surkes J, Brennan FJ. Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol 2004;20:1314–1320. 20. Barbic F, Casazza G, Zamuner AR, Costantino G, Orlandi M, Dipaola F, Capitanio C, Achenza S, Sheldon R, Furlan R. Driving and working with syncope. Auton Neurosci 2014;184:46–52.